Cargando…
Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
Biomarkers of systemic inflammation/nutritional status have been associated with outcomes in advanced-stage non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). However, most of them were not tested in cohorts of patients treated with ICIs in combination with chemothe...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966997/ https://www.ncbi.nlm.nih.gov/pubmed/36835030 http://dx.doi.org/10.3390/ijms24043618 |
_version_ | 1784897155470721024 |
---|---|
author | Mahiat, Cédric Bihin, Benoît Duplaquet, Fabrice Stanciu Pop, Claudia Dupont, Michael Vander Borght, Thierry Rondelet, Benoît Vanderick, Jean André, Bénédicte Pirard, Lionel Ocak, Sebahat |
author_facet | Mahiat, Cédric Bihin, Benoît Duplaquet, Fabrice Stanciu Pop, Claudia Dupont, Michael Vander Borght, Thierry Rondelet, Benoît Vanderick, Jean André, Bénédicte Pirard, Lionel Ocak, Sebahat |
author_sort | Mahiat, Cédric |
collection | PubMed |
description | Biomarkers of systemic inflammation/nutritional status have been associated with outcomes in advanced-stage non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). However, most of them were not tested in cohorts of patients treated with ICIs in combination with chemotherapy (CT) (ICI + CT) or with CT alone, making it impossible to discriminate a predictive from a prognostic effect. We conducted a single-center retrospective study to search for associations between various baseline biomarkers/scores that reflected the systemic inflammation/nutritional status (Lung Immune Prognostic Index, Modified Lung Immune Prognostic Index, Scottish Inflammatory Prognostic Score, Advanced Lung Cancer Inflammation Index, EPSILoN, Prognostic Nutritional Index, Systemic Immune-Inflammation Index, Gustave Roussy Immune Score, Royal Marsden Hospital Prognostic Score, Lung Immuno-oncology Prognostic Score 3, Lung Immuno-oncology Prognostic Score 4, score published by Holtzman et al., and Glasgow Prognostic Score) and outcomes in metastatic NSCLC treated in a first-line setting either with ICI in monotherapy (cohort 1; n = 75), ICI + CT (cohort 2; n = 56), or CT alone (cohort 3; n = 221). In the three cohorts, the biomarkers/scores were moderately associated with overall survival (OS) and progression-free survival (PFS). Their prognostic performance was relatively poor, with a maximum c-index of 0.66. None of them was specific to ICIs and could help to choose the best treatment modality. The systemic inflammation/nutritional status, associated with outcomes independently of the treatment, is therefore prognostic but not predictive in metastatic NSCLC. |
format | Online Article Text |
id | pubmed-9966997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99669972023-02-26 Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors Mahiat, Cédric Bihin, Benoît Duplaquet, Fabrice Stanciu Pop, Claudia Dupont, Michael Vander Borght, Thierry Rondelet, Benoît Vanderick, Jean André, Bénédicte Pirard, Lionel Ocak, Sebahat Int J Mol Sci Article Biomarkers of systemic inflammation/nutritional status have been associated with outcomes in advanced-stage non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). However, most of them were not tested in cohorts of patients treated with ICIs in combination with chemotherapy (CT) (ICI + CT) or with CT alone, making it impossible to discriminate a predictive from a prognostic effect. We conducted a single-center retrospective study to search for associations between various baseline biomarkers/scores that reflected the systemic inflammation/nutritional status (Lung Immune Prognostic Index, Modified Lung Immune Prognostic Index, Scottish Inflammatory Prognostic Score, Advanced Lung Cancer Inflammation Index, EPSILoN, Prognostic Nutritional Index, Systemic Immune-Inflammation Index, Gustave Roussy Immune Score, Royal Marsden Hospital Prognostic Score, Lung Immuno-oncology Prognostic Score 3, Lung Immuno-oncology Prognostic Score 4, score published by Holtzman et al., and Glasgow Prognostic Score) and outcomes in metastatic NSCLC treated in a first-line setting either with ICI in monotherapy (cohort 1; n = 75), ICI + CT (cohort 2; n = 56), or CT alone (cohort 3; n = 221). In the three cohorts, the biomarkers/scores were moderately associated with overall survival (OS) and progression-free survival (PFS). Their prognostic performance was relatively poor, with a maximum c-index of 0.66. None of them was specific to ICIs and could help to choose the best treatment modality. The systemic inflammation/nutritional status, associated with outcomes independently of the treatment, is therefore prognostic but not predictive in metastatic NSCLC. MDPI 2023-02-10 /pmc/articles/PMC9966997/ /pubmed/36835030 http://dx.doi.org/10.3390/ijms24043618 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mahiat, Cédric Bihin, Benoît Duplaquet, Fabrice Stanciu Pop, Claudia Dupont, Michael Vander Borght, Thierry Rondelet, Benoît Vanderick, Jean André, Bénédicte Pirard, Lionel Ocak, Sebahat Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors |
title | Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors |
title_full | Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors |
title_fullStr | Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors |
title_full_unstemmed | Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors |
title_short | Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors |
title_sort | systemic inflammation/nutritional status scores are prognostic but not predictive in metastatic non-small-cell lung cancer treated with first-line immune checkpoint inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966997/ https://www.ncbi.nlm.nih.gov/pubmed/36835030 http://dx.doi.org/10.3390/ijms24043618 |
work_keys_str_mv | AT mahiatcedric systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT bihinbenoit systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT duplaquetfabrice systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT stanciupopclaudia systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT dupontmichael systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT vanderborghtthierry systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT rondeletbenoit systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT vanderickjean systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT andrebenedicte systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT pirardlionel systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT ocaksebahat systemicinflammationnutritionalstatusscoresareprognosticbutnotpredictiveinmetastaticnonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors |